There is a seemingly limitless number of frameworks for strategy development. Using them well lays a critical foundation for aligning teams and investors and ensuring long term success. Kirsten Carroll will review the role strategy plays in business planning and the importance of not just developing a great one, but also communicating it effectively. She will provide examples of the frameworks that have served her particularly well in her own career with advice on when and how to use them. Download Kirsten's slide deck
Where and When
Room 212, Byers Hall, UCSF Mission Bay (1700 4th St., San Francisco)
5:00 to 6:30 PM, Tuesday, April 3, 2018
5:00 - 5:30 pm: Networking
5:30 - 6:30 pm: Talk and Q&A
About the Speaker
Kirsten Carroll holds over 15 years of experience in product development, marketing, strategy and business development for medical devices in stroke care. In November 2017, she joined Imperative Care (an Incept Company), working under the leadership of Fred Khosravi. Prior to her new role, Kirsten was the Senior Director of Strategic Development at Stryker Neurovascular, leading business intelligence, NV services products and BD deal modeling and diligence activities. Kirsten’s first 8 years at Stryker Neurovascular (previously Boston Scientific) were spent in a succession of marketing management roles in the access and hemorrhagic stroke franchises. During that tenure she acted as marketing lead on multiple product development teams, the MAPS Trial, and ultimately the Target Coil, which went on to realize over $1B in revenue to-date and remains the #1 embolization coil in the world. Following the neurovascular division’s acquisition by Stryker in 2011, Kirsten moved into Marketing Operations, ultimately building it into a 9-person Strategic Development function that managed business development, portfolio planning and business intelligence. She holds 2 patents on pre-shaped microcatheters and is a contributing author on 3 publications in the American Journal of Neuroradiology. Kirsten earned a B.Sc. in biomedical engineering from Yale University and an MBA and MPH from the Haas School of Business at UC Berkeley.